sorry, I should read this forum in a reverse time order
BTW some of the data is here
$RHHBY RO6874281, first IL-2 variant to show activity in monotherapy (some responses in melanoma after failure on checkpoint blockade) #ESMO18pic.twitter.com/lsWwlRttM7
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.